Biotech · Private company
Adiso Therapeutics
Track this companyFree. Adds Adiso Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ART24Phase 1 · Clostridium Difficile Infection RecurrenceClinicalTrials.gov · fetched Nov 12, 2026
- BT051 200 mgPhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- BT051 3200 mgPhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- BT051 800 mgPhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)PHASE1 · COMPLETED · started Nov 30, 2021ClinicalTrials.gov NCT05084261 · fetched Nov 12, 2026
- A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)PHASE1 · COMPLETED · started Feb 27, 2020ClinicalTrials.gov NCT04891965 · fetched Nov 12, 2026